Drug Reference

First-line oral antidiabetic agent that decreases hepatic glucose production and improves insulin sensitivity.

Dihydropyridine calcium channel blocker used to treat hypertension and angina by relaxing vascular smooth muscle.

Statin that reduces LDL cholesterol and triglycerides while increasing HDL through competitive inhibition of HMG-CoA reductase.

Irreversible PPI that suppresses gastric acid secretion by blocking the H+/K+ ATPase enzyme in parietal cells.

Broad-spectrum macrolide antibiotic with prolonged tissue half-life, used for respiratory and skin infections.

Potent loop diuretic inhibiting Na-K-2Cl cotransporter in the thick ascending limb, causing significant fluid and electrolyte excretion.

LMWH that preferentially inhibits Factor Xa, used for DVT prophylaxis and treatment of thromboembolic events.

Synthetic T4 hormone used to treat hypothyroidism and suppress TSH in thyroid cancer.

Centrally-acting analgesic with weak opioid agonist activity and monoamine reuptake inhibition, used for moderate-to-severe pain.

Short-acting beta-2 agonist that relaxes bronchial smooth muscle, used for acute bronchospasm and asthma rescue therapy.

ARB that selectively blocks AT1 receptors, reducing vasoconstriction and aldosterone secretion for BP and nephroprotection.

Irreversible ADP receptor inhibitor that inhibits platelet aggregation, used for secondary prevention of atherothrombotic events.